EUVIMEDOpdag EUVIMED
Crossref

Diagnosis of Cutaneous Acute Graft‑Versus‑Host Disease Through Circulating Plasma miR‐638, miR‐6511b‐5p, miR‐3613‐5p, miR‐455‐3p, miR‐5787, and miR‐548a‐3p as Prospective Noninvasive Biomarkers Following Allogeneic Hematopoietic Stem Cell Transplantation

Marzieh Izadifard iD, Mohammad Ahmadvand iD, Hossein Pashaiefar iD, Kamran Alimoghadam iD, Amir Kasaeian iD, Maryam Barkhordar iD, Ghazal Seghatoleslami iD, Mohammad Vaezi iD, Ardeshir Ghavamzadeh iD, Marjan Yaghmaie iD

Clinical Transplantation · 2024

DOI: 10.1111/ctr.15371 ↗

At a glance

Journal article in Clinical Transplantation, 2024. Written by Marzieh Izadifard and 9 co-authors. Institution: Hematology, Oncology and Stem Cell Transplantation Research Center, Research Institute for Oncology, Hematology and Cell Therapy, Shariati Hospital, …. Major MEDLINE topics: Graft vs Host Disease, MicroRNAs, Hematopoietic Stem Cell Transplantation, Biomarkers. Cited 1 times so far (Crossref); 46 references. Funded by: Tehran University of Medical Sciences, Tehran, Iran, and Student Research Committee, Tehran University of Medical Sciences, Tehran, Iran.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

There are currently no laboratory tests that can accurately predict the likelihood of developing acute graft‐versus‐host disease (aGVHD), a patient's response to treatment, or their survival chance. This research aimed to establish circulating miRNAs as diagnostic, prognostic, or predictive biomarkers of aGVHD.

Methods

In a prospective cohort, we studied the incidence of cutaneous aGVHD in AML patients undergoing allo‐HSCT at Shariati Hospital in Tehran, Iran during 2020–2023. Patients with cutaneous aGVHD were labeled as the case group, while patients without cutaneous aGVHD were selected as the control group. Accordingly, the expression levels of six significant miRNAs (miR‐638, miR‐6511b‐5p, miR‐3613‐5p, miR‐455‐3p, miR‐5787, miR‐548a‐3p) were evaluated by quantitative reverse transcription–polymerase chain reaction (RTqPCR) in three different time‐points: before transplantation, on day 14 and day 21 after transplantation.

Results

The levels of plasma miR‐455‐3p, miR‐5787, miR‐638, and miR‐3613‐5p were significantly downregulated, while miR‐548a‐3p, and miR‐6511b‐5p were significantly upregulated in individuals with cutaneous aGVHD in comparison to patients without GVHD. Additionally, the possibility for great diagnostic accuracy for cutaneous aGVHD was revealed by ROC curve analysis of differentially expressed miRNAs (DEMs).

Conclusion

The study findings encourage us to hypothesize that the aforementioned miRNAs may contribute to the predominance of aGVHD, particularly low‐grade cutaneous aGVHD.

Subjects

MeSH terms (MEDLINE)

Graft vs Host DiseaseMicroRNAsHematopoietic Stem Cell TransplantationBiomarkersHumansMaleFemaleProspective StudiesAdultPrognosisMiddle AgedFollow-Up StudiesTransplantation, HomologousCase-Control StudiesYoung AdultAdolescentSkin DiseasesLeukemia, Myeloid, Acute

Author keywords

acute myeloid leukemiacirculating miRNAscutaneous aGVHDdiagnostichematopoietic stem cell transplantationnon‐invasive biomarkers

Substances

MicroRNAsBiomarkers

Authors and institutions

  • Hematology, Oncology and Stem Cell Transplantation Research Center, Research Institute for Oncology, Hematology and Cell Therapy, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
  • Cell Therapy and Hematopoietic Stem Cell Transplantation Research Center, Research Institute for Oncology, Hematology, and Cell Therapy, Tehran University of Medical Sciences, Tehran, Iran.
  • Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • ATMP Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran.

ORCID profiles: Marzieh Izadifard, Mohammad Ahmadvand, Hossein Pashaiefar, Kamran Alimoghadam, Amir Kasaeian, Maryam Barkhordar, Ghazal Seghatoleslami, Mohammad Vaezi, Ardeshir Ghavamzadeh, Marjan Yaghmaie

Funding

  • Tehran University of Medical Sciences, Tehran, Iran, and Student Research Committee
  • Tehran University of Medical Sciences, Tehran, Iran

Cite

APA

Izadifard, M., Ahmadvand, M., Pashaiefar, H., Alimoghadam, K., Kasaeian, A., Barkhordar, M., Seghatoleslami, G., Vaezi, M., Ghavamzadeh, A., & Yaghmaie, M. (2024). Diagnosis of Cutaneous Acute Graft‑Versus‑Host Disease Through Circulating Plasma miR‐638, miR‐6511b‐5p, miR‐3613‐5p, miR‐455‐3p, miR‐5787, and miR‐548a‐3p as Prospective Noninvasive Biomarkers Following Allogeneic Hematopoietic Stem Cell Transplantation. Clinical Transplantation. https://doi.org/10.1111/ctr.15371

Vancouver

Izadifard M, Ahmadvand M, Pashaiefar H, Alimoghadam K, Kasaeian A, Barkhordar M, et al. Diagnosis of Cutaneous Acute Graft‑Versus‑Host Disease Through Circulating Plasma miR‐638, miR‐6511b‐5p, miR‐3613‐5p, miR‐455‐3p, miR‐5787, and miR‐548a‐3p as Prospective Noninvasive Biomarkers Following Allogeneic Hematopoietic Stem Cell Transplantation. Clinical Transplantation. 2024. doi:10.1111/ctr.15371

BibTeX
@article{Izadifard2024,
  author = {Izadifard, Marzieh and Ahmadvand, Mohammad and Pashaiefar, Hossein and Alimoghadam, Kamran and Kasaeian, Amir and Barkhordar, Maryam and Seghatoleslami, Ghazal and Vaezi, Mohammad and Ghavamzadeh, Ardeshir and Yaghmaie, Marjan},
  title = {Diagnosis of Cutaneous Acute Graft‑Versus‑Host Disease Through Circulating Plasma miR‐638, miR‐6511b‐5p, miR‐3613‐5p, miR‐455‐3p, miR‐5787, and miR‐548a‐3p as Prospective Noninvasive Biomarkers Following Allogeneic Hematopoietic Stem Cell Transplantation},
  journal = {Clinical Transplantation},
  year = {2024},
  doi = {10.1111/ctr.15371}
}
Start for free →